Trials / Withdrawn
WithdrawnNCT02632903
Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Children's Hospital of Eastern Ontario · Academic / Other
- Sex
- All
- Age
- 8 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
This study explores the effect of zoledronic acid on incident vertebral fractures and osteonecrotic lesions in children recently diagnosed with acute lymphoblastic leukemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zoledronic acid |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2018-03-01
- Completion
- 2018-08-20
- First posted
- 2015-12-17
- Last updated
- 2018-08-22
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02632903. Inclusion in this directory is not an endorsement.